| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DEMANT.CO - | SELL | -1,190 @ DKK 28.5965 | DKK -34,030 | The ETF sold 1190 shares of DEMANT.CO on 2025-12-10. The shares were previously bought for an average price of DKK 32.2794. The shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of DKK 4,383 (USD $682) The average price that the ETF previously sold DEMANT.CO share for is DKK 33.8482 which is higher than the selling price of DKK 28.5965 on 2025-12-10. |
| HIK.L - | SELL | -2,058 @ GBP 17.5059 | GBP -36,027 | The ETF sold 2058 shares of HIK.L on 2025-12-10. The shares were previously bought for an average price of GBP 22.3835. The shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of GBP 10,038 (USD $13,354) The average price that the ETF previously sold HIK.L share for is GBP 22.6764 which is higher than the selling price of GBP 17.5059 on 2025-12-10. |
| GRF.MC - Grifols SA | SELL | -3,654 @ EUR 10.705 | EUR -39,116 | The ETF sold 3654 shares of GRF.MC on 2025-12-10. The shares were previously bought for an average price of EUR 10.6752. The Grifols SA shares were sold for 0.3% higher than average price of previous purchases. This sale made a profit of EUR 109 (USD $127) The average price that the ETF previously sold GRF.MC share for is EUR 10.4236 so the ETF has sold 3654 shares on 2025-12-10 at a higher price than the previous selling average. |
| BIM.PA - BioMerieux | SELL | -504 @ EUR 104.5 | EUR -52,668 | The ETF sold 504 shares of BIM.PA on 2025-12-10. The shares were previously bought for an average price of EUR 114.199. The BioMerieux shares were sold for -8.5% lower than average price of previous purchases. This resulted in an overall loss of EUR 4,888 (USD $5,684) The average price that the ETF previously sold BIM.PA share for is EUR 110.786 which is higher than the selling price of EUR 104.5 on 2025-12-10. |
| TUB.BR - Financiere de Tubize SA | SELL | -252 @ EUR 216 | EUR -54,432 | The ETF sold 252 shares of TUB.BR on 2025-12-10. The shares were previously bought for an average price of EUR 210.25. The Financiere de Tubize SA shares were sold for 2.7% higher than average price of previous purchases. This sale made a profit of EUR 1,449 (USD $1,685) The average price that the ETF previously sold TUB.BR share for is EUR 218.509 which is higher than the selling price of EUR 216 on 2025-12-10. |
| IPN.PA - Ipsen SA | SELL | -462 @ EUR 121.5 | EUR -56,133 | The ETF sold 462 shares of IPN.PA on 2025-12-10. The shares were previously bought for an average price of EUR 110.554. The Ipsen SA shares were sold for 9.9% higher than average price of previous purchases. This sale made a profit of EUR 5,057 (USD $5,880) The average price that the ETF previously sold IPN.PA share for is EUR 109.598 so the ETF has sold 462 shares on 2025-12-10 at a higher price than the previous selling average. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | SELL | -1,414 @ EUR 47.26 | EUR -66,826 | The ETF sold 1414 shares of REC.MI on 2025-12-10. The shares were previously bought for an average price of EUR 52.7383. The Recordati Industria Chimica e Farmaceutica SpA shares were sold for -10.4% lower than average price of previous purchases. This resulted in an overall loss of EUR 7,746 (USD $9,008) The average price that the ETF previously sold REC.MI share for is EUR 50.9532 which is higher than the selling price of EUR 47.26 on 2025-12-10. |
| SOBI.ST - | SELL | -2,422 @ SEK 30.4099 | SEK -73,653 | The ETF sold 2422 shares of SOBI.ST on 2025-12-10. The shares were previously bought for an average price of SEK 26.7864. The shares were sold for 13.5% higher than average price of previous purchases. This sale made a profit of SEK 8,776 (USD $938) The average price that the ETF previously sold SOBI.ST share for is SEK 27.5635 so the ETF has sold 2422 shares on 2025-12-10 at a higher price than the previous selling average. |
| DIM.PA - Sartorius Stedim Biotech | SELL | -364 @ EUR 209.5 | EUR -76,258 | The ETF sold 364 shares of DIM.PA on 2025-12-10. The shares were previously bought for an average price of EUR 192.964. The Sartorius Stedim Biotech shares were sold for 8.6% higher than average price of previous purchases. This sale made a profit of EUR 6,019 (USD $6,999) The average price that the ETF previously sold DIM.PA share for is EUR 193.049 so the ETF has sold 364 shares on 2025-12-10 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -322 @ EUR 252 | EUR -81,144 | The ETF sold 322 shares of SRT3.DE on 2025-12-10. The shares were previously bought for an average price of EUR 217.069. The Sartorius AG shares were sold for 16.1% higher than average price of previous purchases. This sale made a profit of EUR 11,248 (USD $13,079) The average price that the ETF previously sold SRT3.DE share for is EUR 226.738 so the ETF has sold 322 shares on 2025-12-10 at a higher price than the previous selling average. |
| ORNBV.HE - Orion Oyj | SELL | -1,344 @ EUR 61.05 | EUR -82,051 | The ETF sold 1344 shares of ORNBV.HE on 2025-12-10. The shares were previously bought for an average price of EUR 59.669. The Orion Oyj shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of EUR 1,856 (USD $2,158) The average price that the ETF previously sold ORNBV.HE share for is EUR 55.1072 so the ETF has sold 1344 shares on 2025-12-10 at a higher price than the previous selling average. |
| ERF.PA - Eurofins Scientific SE | SELL | -1,456 @ EUR 57.46 | EUR -83,662 | The ETF sold 1456 shares of ERF.PA on 2025-12-10. The shares were previously bought for an average price of EUR 57.6515. The Eurofins Scientific SE shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of EUR 279 (USD $324) The average price that the ETF previously sold ERF.PA share for is EUR 53.8452 so the ETF has sold 1456 shares on 2025-12-10 at a higher price than the previous selling average. |
| QIA.DE - QIAGEN NV | SELL | -2,674 @ EUR 39.3 | EUR -105,088 | The ETF sold 2674 shares of QIA.DE on 2025-12-10. The shares were previously bought for an average price of EUR 39.6413. The QIAGEN NV shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 913 (USD $1,061) The average price that the ETF previously sold QIA.DE share for is EUR 38.6249 so the ETF has sold 2674 shares on 2025-12-10 at a higher price than the previous selling average. |
| FME.DE - Fresenius Medical Care AG | SELL | -2,716 @ EUR 39.94 | EUR -108,477 | The ETF sold 2716 shares of FME.DE on 2025-12-10. The shares were previously bought for an average price of EUR 45.9708. The Fresenius Medical Care AG shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of EUR 16,380 (USD $19,047) The average price that the ETF previously sold FME.DE share for is EUR 45.6923 which is higher than the selling price of EUR 39.94 on 2025-12-10. |
| COLO-B.CO - | SELL | -1,554 @ DKK 75.3202 | DKK -117,048 | The ETF sold 1554 shares of COLO-B.CO on 2025-12-10. The shares were previously bought for an average price of DKK 83.2028. The shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of DKK 12,250 (USD $1,907) The average price that the ETF previously sold COLO-B.CO share for is DKK 85.9116 which is higher than the selling price of DKK 75.3202 on 2025-12-10. |
| SOON.SW - | SELL | -630 @ CHF 213.924 | CHF -134,772 | The ETF sold 630 shares of SOON.SW on 2025-12-10. The shares were previously bought for an average price of CHF 260.436. The shares were sold for -17.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 29,303 (USD $36,360) The average price that the ETF previously sold SOON.SW share for is CHF 283.808 which is higher than the selling price of CHF 213.924 on 2025-12-10. |
| STMN.SW - | SELL | -1,372 @ CHF 98.2829 | CHF -134,844 | The ETF sold 1372 shares of STMN.SW on 2025-12-10. The shares were previously bought for an average price of CHF 109.888. The shares were sold for -10.6% lower than average price of previous purchases. This resulted in an overall loss of CHF 15,922 (USD $19,757) The average price that the ETF previously sold STMN.SW share for is CHF 112.996 which is higher than the selling price of CHF 98.2829 on 2025-12-10. |
| RO.SW - | SELL | -392 @ CHF 354.863 | CHF -139,106 | The ETF sold 392 shares of RO.SW on 2025-12-10. The shares were previously bought for an average price of CHF 304.239. The shares were sold for 16.6% higher than average price of previous purchases. This sale made a profit of CHF 19,845 (USD $24,624) The average price that the ETF previously sold RO.SW share for is CHF 304.679 so the ETF has sold 392 shares on 2025-12-10 at a higher price than the previous selling average. |
| SN.L - Smith & Nephew PLC | SELL | -9,912 @ GBP 14.2908 | GBP -141,650 | The ETF sold 9912 shares of SN.L on 2025-12-10. The shares were previously bought for an average price of GBP 13.6992. The Smith & Nephew PLC shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of GBP 5,864 (USD $7,800) The average price that the ETF previously sold SN.L share for is GBP 13.1702 so the ETF has sold 9912 shares on 2025-12-10 at a higher price than the previous selling average. |
| SHL.DE - Siemens Healthineers AG | SELL | -4,172 @ EUR 42.99 | EUR -179,354 | The ETF sold 4172 shares of SHL.DE on 2025-12-10. The shares were previously bought for an average price of EUR 47.1994. The Siemens Healthineers AG shares were sold for -8.9% lower than average price of previous purchases. This resulted in an overall loss of EUR 17,562 (USD $20,421) The average price that the ETF previously sold SHL.DE share for is EUR 48.2041 which is higher than the selling price of EUR 42.99 on 2025-12-10. |
| MRK.DE - Merck KGaA | SELL | -1,596 @ EUR 116.3 | EUR -185,615 | The ETF sold 1596 shares of MRK.DE on 2025-12-10. The shares were previously bought for an average price of EUR 117.731. The Merck KGaA shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of EUR 2,284 (USD $2,657) The average price that the ETF previously sold MRK.DE share for is EUR 123.404 which is higher than the selling price of EUR 116.3 on 2025-12-10. |
| GMAB.CO - | SELL | -756 @ DKK 266.619 | DKK -201,564 | The ETF sold 756 shares of GMAB.CO on 2025-12-10. The shares were previously bought for an average price of DKK 209.088. The shares were sold for 27.5% higher than average price of previous purchases. This sale made a profit of DKK 43,493 (USD $6,772) The average price that the ETF previously sold GMAB.CO share for is DKK 203.815 so the ETF has sold 756 shares on 2025-12-10 at a higher price than the previous selling average. |
| PHIA.AS - Koninklijke Philips NV | SELL | -9,492 @ EUR 23 | EUR -218,316 | The ETF sold 9492 shares of PHIA.AS on 2025-12-10. The shares were previously bought for an average price of EUR 22.3589. The Koninklijke Philips NV shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of EUR 6,085 (USD $7,076) The average price that the ETF previously sold PHIA.AS share for is EUR 23.1011 which is higher than the selling price of EUR 23 on 2025-12-10. |
| FRE.DE - Fresenius SE & Co KGaA | SELL | -5,208 @ EUR 48.04 | EUR -250,192 | The ETF sold 5208 shares of FRE.DE on 2025-12-10. The shares were previously bought for an average price of EUR 42.6885. The Fresenius SE & Co KGaA shares were sold for 12.5% higher than average price of previous purchases. This sale made a profit of EUR 27,871 (USD $32,409) The average price that the ETF previously sold FRE.DE share for is EUR 41.0203 so the ETF has sold 5208 shares on 2025-12-10 at a higher price than the previous selling average. |
| SDZ.SW - | SELL | -5,152 @ CHF 63.2461 | CHF -325,844 | The ETF sold 5152 shares of SDZ.SW on 2025-12-10. The shares were previously bought for an average price of CHF 46.9107. The shares were sold for 34.8% higher than average price of previous purchases. This sale made a profit of CHF 84,160 (USD $104,430) The average price that the ETF previously sold SDZ.SW share for is CHF 45.9742 so the ETF has sold 5152 shares on 2025-12-10 at a higher price than the previous selling average. |
| GALD.SW - | SELL | -1,904 @ CHF 179.572 | CHF -341,905 | The ETF sold 1904 shares of GALD.SW on 2025-12-10. The shares were previously bought for an average price of CHF 132.226. The shares were sold for 35.8% higher than average price of previous purchases. This sale made a profit of CHF 90,147 (USD $111,858) The average price that the ETF previously sold GALD.SW share for is CHF 125.664 so the ETF has sold 1904 shares on 2025-12-10 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -1,554 @ EUR 242.2 | EUR -376,379 | The ETF sold 1554 shares of UCB.BR on 2025-12-10. The shares were previously bought for an average price of EUR 189.972. The UCB SA shares were sold for 27.5% higher than average price of previous purchases. This sale made a profit of EUR 81,162 (USD $94,379) The average price that the ETF previously sold UCB.BR share for is EUR 185.522 so the ETF has sold 1554 shares on 2025-12-10 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -6,160 @ CHF 68.5112 | CHF -422,029 | The ETF sold 6160 shares of ALC.SW on 2025-12-10. The shares were previously bought for an average price of CHF 73.8693. The shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of CHF 33,006 (USD $40,955) The average price that the ETF previously sold ALC.SW share for is CHF 77.4525 which is higher than the selling price of CHF 68.5112 on 2025-12-10. |
| BAYN.DE - Bayer AG | SELL | -12,110 @ EUR 36.615 | EUR -443,408 | The ETF sold 12110 shares of BAYN.DE on 2025-12-10. The shares were previously bought for an average price of EUR 25.5091. The Bayer AG shares were sold for 43.5% higher than average price of previous purchases. This sale made a profit of EUR 134,492 (USD $156,392) The average price that the ETF previously sold BAYN.DE share for is EUR 24.2649 so the ETF has sold 12110 shares on 2025-12-10 at a higher price than the previous selling average. |
| HLN.L - Haleon PLC | SELL | -109,522 @ GBP 4.07556 | GBP -446,363 | The ETF sold 109522 shares of HLN.L on 2025-12-10. The shares were previously bought for an average price of GBP 4.39824. The Haleon PLC shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of GBP 35,341 (USD $47,015) The average price that the ETF previously sold HLN.L share for is GBP 4.47744 which is higher than the selling price of GBP 4.07556 on 2025-12-10. |
| LONN.SW - | SELL | -868 @ CHF 575.529 | CHF -499,559 | The ETF sold 868 shares of LONN.SW on 2025-12-10. The shares were previously bought for an average price of CHF 603.713. The shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of CHF 24,464 (USD $30,356) The average price that the ETF previously sold LONN.SW share for is CHF 585.69 which is higher than the selling price of CHF 575.529 on 2025-12-10. |
| ARGX.BR - Argenx SE | SELL | -756 @ EUR 770.2 | EUR -582,271 | The ETF sold 756 shares of ARGX.BR on 2025-12-10. The shares were previously bought for an average price of EUR 585.67. The Argenx SE shares were sold for 31.5% higher than average price of previous purchases. This sale made a profit of EUR 139,505 (USD $162,220) The average price that the ETF previously sold ARGX.BR share for is EUR 591.072 so the ETF has sold 756 shares on 2025-12-10 at a higher price than the previous selling average. |
| GSK.L - GlaxoSmithKline PLC | SELL | -49,980 @ GBP 20.6352 | GBP -1,031,347 | The ETF sold 49980 shares of GSK.L on 2025-12-10. The shares were previously bought for an average price of GBP 17.4295. The GlaxoSmithKline PLC shares were sold for 18.4% higher than average price of previous purchases. This sale made a profit of GBP 160,221 (USD $213,155) The average price that the ETF previously sold GSK.L share for is GBP 17.3978 so the ETF has sold 49980 shares on 2025-12-10 at a higher price than the previous selling average. |
| EL.PA - EssilorLuxottica SA | SELL | -3,696 @ EUR 285 | EUR -1,053,360 | The ETF sold 3696 shares of EL.PA on 2025-12-10. The shares were previously bought for an average price of EUR 263.173. The EssilorLuxottica SA shares were sold for 8.3% higher than average price of previous purchases. This sale made a profit of EUR 80,673 (USD $93,807) The average price that the ETF previously sold EL.PA share for is EUR 262.015 so the ETF has sold 3696 shares on 2025-12-10 at a higher price than the previous selling average. |
| SAN.PA - Sanofi SA | SELL | -13,580 @ EUR 82.68 | EUR -1,122,794 | The ETF sold 13580 shares of SAN.PA on 2025-12-10. The shares were previously bought for an average price of EUR 87.044. The Sanofi SA shares were sold for -5.0% lower than average price of previous purchases. This resulted in an overall loss of EUR 59,263 (USD $68,913) The average price that the ETF previously sold SAN.PA share for is EUR 91.0926 which is higher than the selling price of EUR 82.68 on 2025-12-10. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -39,606 @ DKK 41.3819 | DKK -1,638,972 | The ETF sold 39606 shares of NOVO-B.CO on 2025-12-10. The shares were previously bought for an average price of DKK 54.3016. The Novo Nordisk A/S shares were sold for -23.8% lower than average price of previous purchases. This resulted in an overall loss of DKK 511,698 (USD $79,675) The average price that the ETF previously sold NOVO-B.CO share for is DKK 53.6528 which is higher than the selling price of DKK 41.3819 on 2025-12-10. |
| NOVN.SW - | SELL | -23,380 @ CHF 112.816 | CHF -2,637,638 | The ETF sold 23380 shares of NOVN.SW on 2025-12-10. The shares were previously bought for an average price of CHF 104.297. The shares were sold for 8.2% higher than average price of previous purchases. This sale made a profit of CHF 199,174 (USD $247,120) The average price that the ETF previously sold NOVN.SW share for is CHF 102.229 so the ETF has sold 23380 shares on 2025-12-10 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -19,068 @ GBP 154.624 | GBP -2,948,370 | The ETF sold 19068 shares of AZN.L on 2025-12-10. The shares were previously bought for an average price of GBP 132.331. The AstraZeneca PLC shares were sold for 16.8% higher than average price of previous purchases. This sale made a profit of GBP 425,083 (USD $565,517) The average price that the ETF previously sold AZN.L share for is GBP 131.814 so the ETF has sold 19068 shares on 2025-12-10 at a higher price than the previous selling average. |
| ROG.SW - | SELL | -8,638 @ CHF 344.59 | CHF -2,976,568 | The ETF sold 8638 shares of ROG.SW on 2025-12-10. The shares were previously bought for an average price of CHF 288.914. The shares were sold for 19.3% higher than average price of previous purchases. This sale made a profit of CHF 480,929 (USD $596,759) The average price that the ETF previously sold ROG.SW share for is CHF 289.487 so the ETF has sold 8638 shares on 2025-12-10 at a higher price than the previous selling average. |